about
Improving therapeutic efficacy of a complement receptor by structure-based affinity maturation.Inhibitors of complement activity in human breast-milk: a proposed hypothesis of their physiological significanceC5a alters blood-brain barrier integrity in experimental lupus.Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury.Alternative pathway fof bovine complement Immunochemical studies on factor B-like serum protein and its conversion product B gamma 2.Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury.Immune complexes in human diseases: a reviewImmunopathology.Partial sequence of human complement component factor B: novel type of serine protease.Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphismThe acute effects of antiglomerular basement membrane antibody upon glomerular filtration in the rat. The influence of dose and complement depletionDiscrimination between host and pathogens by the complement system.Regulation of macrophage migration by products of the complement system.Activation of the alternative pathway of human complement by haemoglobin.Human complement activation by lipopolysaccharides from bacteroides oralis, fusobacterium nucleatum, and veillonella parvula.Immunopharmacological control of inflammation.The purification and properties of the second component of human complement.The C3 convertase of the alternative pathway of human complement. Enzymic properties of the bimolecular proteinase.Purification and characterization of subcomponent C1q of the first component of mouse complement.Acute phase proteins, C9, factor B, and lysozyme in recurrent oral ulceration and Behçet's syndrome
P2860
Q33510862-135CD0DC-CF53-4BE8-B535-9E77950F26A0Q33855076-BBCC8D6F-D79A-4745-BED4-4090634FFE10Q33868735-B95F2588-ADD6-4310-A4D6-8B4FA1F46420Q34162118-F2FE5D73-0A4D-46C7-A826-E3042E0B6388Q34239537-CDEA67D2-8987-49DA-8284-5C8F703EAB5AQ34572148-64F27BCF-78CC-4523-802B-AF298170B010Q35863255-07288FA1-62A8-4A95-B0C2-229E529A3C8FQ36058579-44CDA137-A7E1-4CBC-A7D6-88149687F98CQ36403444-6C8C256D-AEE6-40F7-BDE0-B5C44398F9E9Q36586617-F816267D-4B34-4B91-98BE-F6EDF3D271EBQ37052702-4AFC9755-E85A-49AA-9EF2-1A7ECF26F5A7Q37170042-CF1FCB54-D5EF-4127-8FFF-BC92F02788EEQ37316278-2A9AB75B-325C-4209-897D-E67D630DCBA1Q39676453-B9C614DE-285F-4FD0-AA02-7E2145313889Q39718366-A7FEA5EC-EA93-462A-B6E3-87DB3CF5B6F6Q41253539-EE429659-A845-47BD-B8B2-760F055C2AD9Q41400042-53D2EE78-2EBA-4579-A19E-3E36D6551566Q41761011-EF4B5A5B-638D-42C2-896D-58B09DBA621CQ42012531-1F0A4F89-222C-43D3-8483-0DAB969EEC40Q42064234-88BB3F7A-500D-4E41-96C6-D42DED8DCB6D
P2860
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年論文
@yue
1976年論文
@zh-hant
1976年論文
@zh-hk
1976年論文
@zh-mo
1976年論文
@zh-tw
1976年论文
@wuu
1976年论文
@zh
1976年论文
@zh-cn
name
The alternative pathway of complement activation.
@en
type
label
The alternative pathway of complement activation.
@en
prefLabel
The alternative pathway of complement activation.
@en
P1476
The alternative pathway of complement activation.
@en
P2093
Müller-Eberhard HJ
P577
1976-01-01T00:00:00Z